AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Precision BioSciencesCellular Biomedicine GroupBioCryst PharmaceuticalsVoyager TherapeuticsHarpoon Therapeutics
SymbolNASDAQ:DTILNASDAQ:CBMGNASDAQ:BCRXNASDAQ:VYGRNASDAQ:HARP
Price Information
Current Price$7.14$13.13$4.73$12.58$18.28
52 Week RangeBuyHoldBuyBuyBuy
Beat the Market™ Rank
Overall Score1.61.11.51.71.3
Analysis Score3.43.23.34.43.5
Community Score3.02.32.62.72.2
Dividend Score0.00.00.00.00.0
Ownership Score1.00.01.01.01.0
Earnings & Valuation Score0.60.00.60.60.0
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$20.67$21.67$7.60$18.56$31.17
% Upside from Price Target189.45% upside65.02% upside60.68% upside47.50% upside70.50% upside
Trade Information
Market Cap$370.28 million$267.02 million$693.83 million$450.01 million$451.63 million
Beta1.71.582.781.931.3
Average Volume560,09467,8308,384,847364,747142,392
Sales & Book Value
Annual Revenue$22.24 million$340,000.00$48.83 million$104.39 million$5.78 million
Price / Sales16.65748.8314.954.4879.06
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.72 per share$2.89 per share$0.26 per share$2.68 per share$3.82 per share
Price / Book2.634.5418.194.694.79
Profitability
Net Income$-92,880,000.00$-49,980,000.00$-108,900,000.00$-43,600,000.00$-55,570,000.00
EPS($1.91)($2.63)($0.94)($1.21)($2.55)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-369.86%N/A-241.66%-34.70%-681.41%
Return on Equity (ROE)-60.32%-83.10%-4,223.68%-40.11%-53.62%
Return on Assets (ROA)-35.83%-51.14%-89.02%-11.29%-34.20%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A11.03%N/A0.16%
Current Ratio7.02%1.00%1.35%3.76%5.40%
Quick Ratio7.02%1.00%1.35%3.76%5.40%
Ownership Information
Institutional Ownership Percentage49.35%21.96%79.53%80.51%77.13%
Insider Ownership Percentage14.30%9.10%4.30%22.90%34.90%
Miscellaneous
Employees12719310012345
Shares Outstanding51.86 million19.39 million154.36 million37.19 million25.00 million
Next Earnings Date8/12/2020 (Estimated)8/4/2020 (Estimated)8/4/2020 (Estimated)8/14/2020 (Estimated)8/3/2020 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.